Verheye S, Ferdinande B, Bennett J, Staico R, et al. Site-Specific Antithrombotic Therapy: 24-Month Outcomes of the Randomized DESyne BDS Plus Trial Using a Novel Triple-Drug Eluting Coronary Implant With Two Anticoagulants and Sirolimus. Catheter Cardiovasc Interv 2025;106:2770-2780.
PMID: 40873231